Eylea

Aflibercept

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and the European Union.[2][3] It is an inhibitor of vascular endothelial growth factor (VEGF).[4][5] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism of action ...

Aflibercept

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and the European Union.[2][3] It is an inhibitor of vascular endothelial growth factor (VEGF).[4][5] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism of action ...

Has anyone experienced loss of smell and taste since getting injections? ## What did your retinal specialist say about the cause of loss of smell and taste? Were you on Lucentis or Avastin before the start of Eylea? ## I haven't been able to find any information that lists such symptoms as being known side effects of this medication, but it's very difficult to know how any drug will affect any given person that takes it. Have you contacted your doctor about it? Learn more Eylea details here. ## I have been having inj's. for amd since Oct 2010. First Lucentic for about a year, then Avastin. I have now had about 26 inj's. of eyelia. I lost my sense of smell in 2015 and saw ent specialists. I had a CT scan and an MRI scan but nothing found. The specialist put it down to a v...

7 REPLIES

Ziv aflibercept

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and the European Union.[2][3] It is an inhibitor of vascular endothelial growth factor (VEGF).[4][5] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism of action ...

Drug Index

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and the European Union.[2][3] It is an inhibitor of vascular endothelial growth factor (VEGF).[4][5] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism of action ...

Drug Index

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and the European Union.[2][3] It is an inhibitor of vascular endothelial growth factor (VEGF).[4][5] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism of action ...

NDC Database

Eylea 40 mg/ml Intravitreal Injection, Solution by Regeneron Pharmaceuticals, Inc. ## Package Codes: 61755-005-01, 61755-005-02, 61755-005-54, 61755-005-55 ## Active Ingredients: Aflibercept